Inhibrx Biosciences Reports Third Quarter 2024 Financial Results

Go back to Inhibrx Biosciences Reports Third Quarter 2024 Financial Results
(NASDAQ: INBX) Delayed: 103.63 +4.48 (4.52%)
Previous Close $99.15    52 Week High
Open $100.76    52 Week Low
Day High $105.65    P/E N/A 
Day Low $99.05    EPS
Volume 220,745